Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILENT TECHNOLOGIES, INC.

(A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Agilent Technologies : Announces Optimized and Verified Method for Testing Over 100 PFAS Compounds

07/20/2021 | 08:24am EST

Agilent Technologies Inc. (NYSE: A) today announced the availability of an optimized and verified eMethod for PFAS Analysis in Water by LC/TQ for testing per- and polyfluoroalkyl substances (PFAS) in drinking and surface water using liquid chromatography and mass spectrometry.

PFAS-known as 'forever chemicals'-are a group of man-made chemicals that include PFOA, PFOS, GenX, and many others. PFAS have been manufactured and used in a variety of industries worldwide since the 1940s. Environmental contamination of PFAS compounds continues to be a highly visible environmental issue.

'Regulators across the globe continue to implement or evolve guidance, which is pushing our environmental customers to add this analysis to their portfolio or update their existing analysis,' said Tarun Anumol, Ph.D., director of Agilent's Global Environment and Food Applied Markets. 'This solution provides users a fully-developed workflow for the analysis of legacy and emerging PFAS including sample preparation, analysis, and reporting.'

Customers can now use Agilent's PFAS drinking and surface water solution to run real samples within hours, eliminating the requirement for an exhaustive investigation, optimization, and method development that often took weeks. The solution includes optimized analytical protocols (sample preparation protocol, step-by-step workflow guide, and ready-to-run acquisition and quantitation methods) and a detailed list of consumables, supplies, and lab equipment necessary to implement the complete analytical protocol.

'More than 100 PFAS compounds are included in this method covering all important regulations, so customers can stay relevant as regulations are updated, and can also future-proof their PFAS analysis with several emerging PFAS,' Anumol added.

Disclaimer

Agilent Technologies Inc. published this content on 20 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 July 2021 12:23:01 UTC.


ę Publicnow 2021
All news about AGILENT TECHNOLOGIES, INC.
11/23Agilent to Present at Evercore ISI Virtual Healthcare Conference
BU
11/23Stifel Adjusts Price Target for Agilent Technologies to $169 From $162, Maintains Hold ..
MT
11/23SVB Leerink Adjusts Agilent Technologies' Price Target to $175 from $170, Keeps Outperf..
MT
11/23Health Care Stocks Flat Ahead of Tuesday's Opening Bell
MT
11/22AGILENT TECHNOLOGIES : Prepared Remarks (opens in new window)
PU
11/22AGILENT : Fiscal Q4 Earnings Snapshot
AQ
11/22Agilent Technologies Fiscal Q4 non-GAAP EPS, Revenue Rise
MT
11/22AGILENT TECHNOLOGIES : Reports Fourth-Quarter and Fiscal Year 2021 Financial Results - For..
PU
11/22Earnings Flash (A) AGILENT TECHNOLOGIES Posts Q4 Revenue $1.66B, vs. Street Est of $1.6..
MT
11/22Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
BU
More news
Analyst Recommendations on AGILENT TECHNOLOGIES, INC.
More recommendations
Financials (USD)
Sales 2021 6 318 M - -
Net income 2021 1 075 M - -
Net Debt 2021 1 485 M - -
P/E ratio 2021 42,8x
Yield 2021 0,51%
Capitalization 45 206 M 45 206 M -
EV / Sales 2021 7,39x
EV / Sales 2022 6,82x
Nbr of Employees 17 000
Free-Float 100,0%
Chart AGILENT TECHNOLOGIES, INC.
Duration : Period :
Agilent Technologies, Inc. Technical Analysis Chart | A | US00846U1016 | MarketScreener
Technical analysis trends AGILENT TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 149,33 $
Average target price 173,80 $
Spread / Average Target 16,4%
EPS Revisions
Managers and Directors
Michael R. McMullen President, Chief Executive Officer & Director
Robert W. McMahon Chief Financial Officer & Senior Vice President
Boon Hwee Koh Non-Executive Chairman
Darlene J. S. Solomon Chief Technology Officer & Senior Vice President
Katharine Knobil Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
AGILENT TECHNOLOGIES, INC.25.08%45 206
THERMO FISHER SCIENTIFIC36.57%250 658
DANAHER CORPORATION40.88%223 620
INTUITIVE SURGICAL, INC.20.03%114 898
SIEMENS HEALTHINEERS AG52.50%80 761
EDWARDS LIFESCIENCES CORPORATION20.38%67 728